Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hansjoerg Keller

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Bone|June 11, 2005
SOST is a target gene for PTH in boneHansjoerg Keller, Michaela Kneissel
Trends in Endocrinology and Metabolism: TEM|January 16, 2010
Does osteocytic SOST suppression mediate PTH bone anabolism?Ina Kramer, Hansjoerg Keller, Olivier Leupin, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|December 14, 2011
Mef2c deletion in osteocytes results in increased bone massIna Kramer, Stefan Baertschi, Christine Halleux, et al.
The Journal of Biological Chemistry|July 12, 2014
Class I and IIa histone deacetylases have opposite effects on sclerostin gene regulationStefan Baertschi, Nina Baur, Valerie Lueders-Lefevre, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|July 15, 2009
Parathyroid hormone (PTH)-induced bone gain is blunted in SOST overexpressing and deficient miceIna Kramer, Gabriela G Loots, Anne Studer, et al.
SLAS Technology|June 14, 2018
A Novel Microplate 3D Bioprinting Platform for the Engineering of Muscle and Tendon TissuesSandra Laternser, Hansjoerg Keller, Olivier Leupin, et al.
Bone|December 14, 2011
TGF-β regulates sclerostin expression via the ECR5 enhancerGabriela G Loots, Hansjoerg Keller, Olivier Leupin, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|August 19, 2007
Control of the SOST bone enhancer by PTH using MEF2 transcription factorsOlivier Leupin, Ina Kramer, Nicole M Collette, et al.
Journal of Medicinal Chemistry|January 22, 2005
Selective estrogen receptor modulators with conformationally restricted side chains. Synthesis and structure-activity relationship of ERalpha-selective tetrahydroisoquinoline ligandsJohanne Renaud, Serge François Bischoff, Thomas Buhl, et al.
Molecular and Cellular Biology|April 21, 2010
Osteocyte Wnt/beta-catenin signaling is required for normal bone homeostasisIna Kramer, Christine Halleux, Hansjoerg Keller, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Bone|June 11, 2005
SOST is a target gene for PTH in boneHansjoerg Keller, Michaela Kneissel
Trends in Endocrinology and Metabolism: TEM|January 16, 2010
Does osteocytic SOST suppression mediate PTH bone anabolism?Ina Kramer, Hansjoerg Keller, Olivier Leupin, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|December 14, 2011
Mef2c deletion in osteocytes results in increased bone massIna Kramer, Stefan Baertschi, Christine Halleux, et al.
The Journal of Biological Chemistry|July 12, 2014
Class I and IIa histone deacetylases have opposite effects on sclerostin gene regulationStefan Baertschi, Nina Baur, Valerie Lueders-Lefevre, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|July 15, 2009
Parathyroid hormone (PTH)-induced bone gain is blunted in SOST overexpressing and deficient miceIna Kramer, Gabriela G Loots, Anne Studer, et al.
SLAS Technology|June 14, 2018
A Novel Microplate 3D Bioprinting Platform for the Engineering of Muscle and Tendon TissuesSandra Laternser, Hansjoerg Keller, Olivier Leupin, et al.
Bone|December 14, 2011
TGF-β regulates sclerostin expression via the ECR5 enhancerGabriela G Loots, Hansjoerg Keller, Olivier Leupin, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|August 19, 2007
Control of the SOST bone enhancer by PTH using MEF2 transcription factorsOlivier Leupin, Ina Kramer, Nicole M Collette, et al.
Journal of Medicinal Chemistry|January 22, 2005
Selective estrogen receptor modulators with conformationally restricted side chains. Synthesis and structure-activity relationship of ERalpha-selective tetrahydroisoquinoline ligandsJohanne Renaud, Serge François Bischoff, Thomas Buhl, et al.
Molecular and Cellular Biology|April 21, 2010
Osteocyte Wnt/beta-catenin signaling is required for normal bone homeostasisIna Kramer, Christine Halleux, Hansjoerg Keller, et al.
Pageof 2